Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism mGluR5 antagonists(Metabotropic glutamate receptor 5 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC19H16F2N4O2 |
InChIKeyRSTNDKZTQBZOCY-AWEZNQCLSA-N |
CAS Registry915226-19-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | - | - | |
Cognition Disorders | Preclinical | - | - | |
Schizophrenia | Preclinical | - | - |